Enhancing T cell therapy through TCR signaling-responsive nanoparticle drug delivery

Adoptive cell therapy (ACT) with antigen-specific T cells has shown remarkable clinical success, but approaches to safely and effectively augment T cell function, especially in solid tumors, remain of great interest. Here we describe a strategy to “backpack” large quantities of supporting protein dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Li, Zheng, Yiran, de Melo, Mariane Bandeira, Mabardi, Llian, Castaño, Ana P., Xie, Yu-Qing, Li, Na, Kudchodkar, Sagar B., Wong, Hing C., Jeng, Emily K., Maus, Marcela V., Irvine, Darrell J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078803/
https://www.ncbi.nlm.nih.gov/pubmed/29985479
http://dx.doi.org/10.1038/nbt.4181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078803/
https://www.ncbi.nlm.nih.gov/pubmed/29985479
http://dx.doi.org/10.1038/nbt.4181

Ejemplares similares